Artificial Retina Aims to Restore Vision in Retinitis Pigmentosa

Four Americans have received an artificial retina since it was approved by the US Food and Drug Administration last year, and a 5th is scheduled to receive the implant next month.

New Efforts to Hasten tPA for Strokes, Heart Attacks

New efforts to speed up treatment in both ambulances and emergency rooms appear to have significantly improved patients' chances of survival and limited their long-term disability

Mild Cognitive Impairment May Hasten Death

Individuals >70 years of age with mild cognitive impairment (MCI) may be at higher risk for early death, compared to similarly-aged, cognitively-normal people.

New Novel Treatments Show Promise for Migraine

Two studies show promise for migraine treatment with genetically engineered humanized anti-calcitonin gene-related peptide (CGRP) antibody, ALD403, and a fully humanized monoclonal antibody to CGRP, LY2951742.